Agenus (AGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agenus (AGEN)

AGEN 3.960

+3.9%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (78)	7/10/2006 9:06:56 AM
From: scaram(o)uche	Read Replies (2) of 146

I've used and preferred it (among the less toxic of adjuvants)...... Message 4112952 Message 3288947 It's really, really old.... patent life left? Started with the old Cambridge Biotech. Long trip, low royalties. That's not to imply that current royalties are low.... know nothing about GSK or recent history. The RIBI adjuvant is, of course, the Corixa adjuvant that you wrote of.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next